Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: lysosomal storage disaeses

May 25, 2026 CD as API / Pharma applications

CDs as Modulators of Regulated Cell Death: Implications for Immunometabolism and Therapeutic Innovation

This review critically examines how cyclodextrins modulate regulated cell death pathways and the implications for immunometabolism and therapeutic translation. Increasing

Continue reading

June 20, 2025 Diagnosis / Drug delivery / Pharma applications

Special issue: Recent Trends in Carbohydrate-Based Therapeutics

Carbohydrates are encountered in many applications across diverse fields, including glycobiology, pharmaceuticals, genetics, material chemistry, polymer chemistry, and the food

Continue reading

July 25, 2023 CD as API / Pharma applications

Long-term administration of intravenous Trappsol® Cyclo™ (HP-β-CD) in Niemann-Pick disease type C1: Results of an international 48-week Phase I/II trial

Niemann-Pick disease type C (NPC) is a rare, fatal, pan-ethnic, autosomal recessive lysosomal storage disease characterized by progressive major organ

Continue reading

July 21, 2023 CD as API / Pharma applications

Remembering Dr. David Begley

With immense sadness we have to announce that an outstanding Scientist, Dr. David Begley passed away on Thursday 6th July

Continue reading

November 22, 2021 Uncategorized

Use of cyclodextrins in diseases and disorders involving phospholipid dysregulation

A patent application by Knut M. Wittkowski (ASDERA LLC, US) entitled “Use of cyclodextrins in diseases and disorders involving phospholipid

Continue reading

Recent Posts

  • 1-Methylcyclopropene: from the CD cavity to the apple tree
  • β-Cyclodextrin inclusion complexes as supramolecular carriers: Established and emerging applications in the food industry
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
  • Paul Janssen was born 100 years ago
  • Adsorption of PFAS to Cationic β-Cyclodextrin Polymers

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (74)
  • CD as API (357)
  • CD derivatives (434)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (818)
  • E-ducation (63)
  • Environmental (144)
  • Events (241)
  • Food (235)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (418)
  • Other industrial use (113)
  • Pharma applications (1,223)
  • Supramolecular systems (44)
  • Uncategorized (169)

Top Posts

  • β-Cyclodextrin inclusion complexes as supramolecular carriers: Established and emerging applications in the food industry
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
  • 1-Methylcyclopropene: from the CD cavity to the apple tree
  • Lanosterol eye drops for cataract treatment
  • HPαCD Therapy: A Breakthrough for Krabbe Disease Treatment
  • Cyclodextrins Meet Cosmetics, a review
  • Adsorption of PFAS to Cationic β-Cyclodextrin Polymers
  • 19th International Symposium on Macrocyclic and Supramolecular Chemistry (ISMSC2025)
  • Cyclodextrin attenuates atherosclerosis by diminishing gasdermin D (GSDMD)-mediated pyroptosis
  • Renal safety of SBECD

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,458 other subscribers
Loading Comments...